Back

S62798, a TAFIa inhibitor, accelerates endogenous thrombolysis in a murine model of pulmonary thromboembolism

29 August 2020 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Antithrombotic Therapy Update Anticoagulants ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Patricia Sansilvestri-Morel

Servier Research Institute, Suresnes (France)

6 More presentations in this session

Presentation thumbnail
First-in-human study to assess the safety, pharmacokinetics and pharmacodynamics of BMS-986177/JNJ-70033093, a direct, reversible, small molecule Factor XIa inhibitor in healthy volunteers
Doctor V. Perera (Berlin, DE)
Abstract Slides
Presentation thumbnail
Favorable therapeutic index of an orally-active small-molecule antagonist of the platelet protease-activated receptor-4, BMS-986141, compared with the P2Y12 antagonist ticagrelor in cynomolgus monkeys
Doctor P. Wong (Princeton, US)
Abstract Slides
Presentation thumbnail
Orodispersible ticagrelor use in acute coronary syndrome patients: the Ticagrelor Administered as Standard Tablet or orodispersiblE foRmulation (TASTER) Study
Professor G. Parodi (Sassari, IT)
Abstract Slides
Presentation thumbnail
Adherence to dual anti-platelet therapy after acute coronary syndrome and its impact on patient outcome
Doctor P. Sulzgruber (Krems an der Donau, AT)
Abstract Slides
Presentation thumbnail
Benefit and risks of extended dual antiplatelet therapy beyond 1 year in high-risk patients after drug-eluting stent implantation
Doctor H. Wang (Beijing, CN)
Abstract Slides

Access the full session

Session thumbnail
Antithrombotic Therapy Update

The Event

Event poster

ESC Congress 2020

29 August - 1 September 2020
You may be interested in
thumbnail
Congress Presentation
State-of-the-art lecture on pharmacotherapy for acute coronary syndromes
thumbnail
Webinar
Antithrombotic treatment for dual pathway inhibition in cardiovascular disease patients
thumbnail
Congress Presentation
Direct oral anticoagulants or warfarin in patients with left ventricular thrombus: a meta-analysis of randomized clinical trials

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources